Jul 28, 2021 7:00 am EDT Castle Biosciences to Participate at the Canaccord Genuity 41st Annual Growth Conference
Jul 26, 2021 7:00 am EDT Castle Biosciences to Release Second Quarter 2021 Financial Results and Host Conference Call on Monday, Aug. 9, 2021
Jul 23, 2021 7:00 am EDT Castle Biosciences Presents New Data Demonstrating DecisionDx®-SCC Complements Current Risk Assessment Methods in Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck
Jul 22, 2021 5:00 pm EDT Castle Biosciences Presents Data on DecisionDx®-Melanoma and DecisionDx®-SCC at SDPA Annual Summer Dermatology Conference 2021
Jun 21, 2021 7:00 am EDT Castle Biosciences is Listed in the Houston Chronicle’s “CHRON 100” as One of the 100 Most Successful Publicly Traded Companies in Houston
May 24, 2021 7:00 am EDT Castle Biosciences to Host Ribbon Cutting Ceremony at New Corporate Headquarters
May 21, 2021 7:00 am EDT Castle Biosciences Supports the American Skin Association with Research Grant
